Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Policies & Guidelines
Filter by Topic
Best Practices
Clinical Guidelines
End-of-Life Care
Health Policy
NCCN 2015 Updates
NCCN Guidelines
Pathways
Patient Advocacy
Patient Navigation
Quality Care
Survivorship
Survivorship Care
Regional Cancer Care Associates: Consolidating Small Practices into a Large Consortium
Best Practices
,
Policies & Guidelines
June 2012, Vol 3, No 4
Value-Based Cancer Care
is focused on examining value within the context of healthcare stakeholder relations. Dr Pecora and his team at Regional Cancer Care Associates (RCCA) have changed the relationship between the practicing oncologist and the payer, which will have substantial effects on value.
Read Article
The End of Health Insurance Companies
By
Ezekiel J. Emanuel
Health Policy
,
Policies & Guidelines
March 2012, Vol 3, No 2
Here’s a bold prediction for the new year. By 2020, the American health insurance industry will be extinct. Insurance companies will be replaced by accountable care organizations (ACOs) —groups of doctors, hospitals and other health care providers who come together to provide the full range of medical care for patients.
Read Article
Wilshire Oncology Medical Home Pilot: Reengineering Cancer Care
Best Practices
,
Policies & Guidelines
March 2012, Vol 3, No 2
Interview with Linda Bosserman, MD, Clinical Oncologist and President of Wilshire Oncology Medical Group, La Verne, CA
Read Article
AMA Delegates and Oncologists Balk at ICD-10 Implementation
By
Caroline Helwick
Health Policy
,
Policies & Guidelines
March 2012, Vol 3, No 2
New Orleans, LA—According to the American Medical Association (AMA) and many oncologists, the
International Classification of Diseases, Tenth Revision (ICD-10)
diagnostic coding system will be a needless and expensive burden to oncology practices, without enhancing patient care.
Read Article
Americans Willing to Pay Hundreds of Dollars Out of Pocket for Cancer Risk Tests
By
Rosemary Frei, MSc
Health Policy
,
Policies & Guidelines
February 2012, Vol 3, No 1
American adults would be willing to pay a median of $263 for a perfect prostate cancer prediction test and $232 for a perfect breast cancer prediction test, according to a recent survey (Neumann PJ, et al. Health Econ. 2012;21:238-251).
Read Article
Direct-to-Consumer Genetic Testing: Concerns Trump Benefits at This Point
By
Caroline Helwick
Health Policy
,
Policies & Guidelines
February 2012, Vol 3, No 1
Miami, FL—Direct-to-consumer (DTC) marketing of genetic tests represents personalized medicine in evolution. High-throughput genetic technologies have made it possible to evaluate individuals at a relatively affordable price, but a number of technologic, social, regulatory, and ethical issues must first be settled before DTC genetic testing takes personalized medicine to new heights.
Read Article
Building a National Patient Advocacy Network in Oncology
By
Rose Gerber
Patient Advocacy
,
Policies & Guidelines
February 2012, Vol 3, No 1
Read Article
Patient Advocacy: A Physician’s Perspective
By
Richard Frame, MD
Patient Advocacy
,
Policies & Guidelines
February 2012, Vol 3, No 1
I never thought it would happen in the United States, but it has. We are critically close to running out of some chemotherapy drugs. It came as a shock to all of us, when we realized how severely the problem of drug shortages has started to affect our patients. The following case is but one example.
Read Article
Paying for Quality: Increasing Shift Toward Value-Based Healthcare
Health Policy
,
Policies & Guidelines
February 2012, Vol 3, No 1
On November 30, 2011, the Office of the Inspector General (OIG) of the US Department of Health and Human Services issued an advisory opinion (No. 11-18) to the web-based physician practice service provider athenahealth, tacitly approving the company’s new online service athenaCoordinator.
Read Article
Ventura County Hematology Oncology Specialists: Efficiencies Crucial for Economic Viability
Best Practices
,
Policies & Guidelines
February 2012, Vol 3, No 1
Ventura County Hematology Oncology Specialists has so far managed to avoid many of the financial difficulties facing a large number of community cancer practices. Value-Based Cancer Care asked Dr Parsa and Ms Rivera to discuss what makes their practice successful from a clinical and a business perspective.
Read Article
Page 8 of 11
2
3
4
5
6
7
8
9
10
11
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma